Life sciences news
-
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis
Wednesday May 24th 2023
Read more
-
Scientists shed light on a sleep peptide involved in Alzheimer’s
Wednesday May 17th 2023
Read more
-
Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic
Monday May 15th 2023
Read more
-
Researchers reveal a crucial process in the working of the immune system
Monday May 15th 2023
Read more
-
Mithra announces completion of recruitment in pediatric study of Estelle in adolescent patients
Thursday May 11th 2023
Read more
-
Biocartis and HiloProbe to collaborate on colorectal cancer test
Tuesday May 9th 2023
Read more
-
Vrije Universiteit Brussel (VUB) and InSphero partner to advance drug discovery for Non-Alcoholic Steatohepatitis
Thursday May 4th 2023
Read more
-
reMYND announces publication in Alzheimer’s and Dementia on pivotal role of cytosolic calcium in Alzheimer’s disease
Thursday May 4th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
Mithra and the University of Liège secure proof-of-concept for novel manufacturing process of E4
Thursday May 4th 2023
Read more
-
flanders.bio and Thermo Fisher Scientific announce strategic partnership to drive innovation and growth
Thursday May 4th 2023
Read more
-
Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer
Wednesday May 3rd 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
